Identifying SARS-CoV-2 Variants of Concern through Saliva-Based RT-qPCR by Targeting Recurrent Mutation Sites
Open Access
- 12 May 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (3), e0079722
- https://doi.org/10.1128/spectrum.00797-22
Abstract
SARS-CoV-2 variants of concern and their many sublineages can be characterized by mutations present within their genetic sequences. These mutations can provide selective advantages such as increased transmissibility and antibody evasion, which influences public health recommendations such as mask mandates, quarantine requirements, and treatment regimens. SARS-CoV-2 variants of concern (VOCs) continue to pose a public health threat which necessitates a real-time monitoring strategy to complement whole genome sequencing. Thus, we investigated the efficacy of competitive probe RT-qPCR assays for six mutation sites identified in SARS-CoV-2 VOCs and, after validating the assays with synthetic RNA, performed these assays on positive saliva samples. When compared with whole genome sequence results, the S Delta 69-70 and ORF1a Delta 3675-3677 assays demonstrated 93.60 and 68.00% accuracy, respectively. The SNP assays (K417T, E484K, E484Q, L452R) demonstrated 99.20, 96.40, 99.60, and 96.80% accuracies, respectively. Lastly, we screened 345 positive saliva samples from 7 to 22 December 2021 using Omicron-specific mutation assays and were able to quickly identify rapid spread of Omicron in Upstate South Carolina. Our workflow demonstrates a novel approach for low-cost, real-time population screening of VOCs. IMPORTANCE SARS-CoV-2 variants of concern and their many sublineages can be characterized by mutations present within their genetic sequences. These mutations can provide selective advantages such as increased transmissibility and antibody evasion, which influences public health recommendations such as mask mandates, quarantine requirements, and treatment regimens. Our RT-qPCR workflow allows for strain identification of SARS-CoV-2 positive saliva samples by targeting common mutation sites shared between variants of concern and detecting single nucleotides present at the targeted location. This differential diagnostic system can quickly and effectively identify a wide array of SARS-CoV-2 strains, which can provide more informed public health surveillance strategies in the future.Keywords
Funding Information
- South Carolina Governor and Joint Bond Review Committee (Committee funding)
- Clemson University (Creative Inquiry)
- HHS | National Institutes of Health (NIGMS 3P20GM121342-03S1)
- National Science Foundation (1757658)
This publication has 41 references indexed in Scilit:
- Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detectionJournal of Clinical Virology, 2020
- Temporal signal and the phylodynamic threshold of SARS-CoV-2Virus Evolution, 2020
- Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional studyClinical Microbiology & Infection, 2020
- Self-collection: An appropriate alternative during the SARS-CoV-2 pandemicJournal of Clinical Virology, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Consistent Detection of 2019 Novel Coronavirus in SalivaClinical Infectious Diseases, 2020
- Pathogen Genomics in Public HealthThe New England Journal of Medicine, 2019
- Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiologyClinical Microbiology & Infection, 2018
- Selection of a Cutoff Value for Real-Time Polymerase Chain Reaction Results to Fit a Diagnostic Purpose: Analytical and Epidemiologic ApproachesJournal of Veterinary Diagnostic Investigation, 2011
- Real-time PCR for mRNA quantitationBioTechniques, 2005